Market capitalization | $12.37m |
Enterprise Value | $9.99m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.33 |
P/S ratio (TTM) P/S ratio | 0.41 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | -16.04% |
Revenue (TTM) Revenue | $30.29m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast Marpai:
1 Analyst has issued a forecast Marpai:
Sep '24 |
+/-
%
|
||
Revenue | 30 30 |
16%
16%
|
|
Gross Profit | 6.50 6.50 |
25%
25%
|
|
EBITDA | -12 -12 |
52%
52%
|
EBIT (Operating Income) EBIT | -16 -16 |
50%
50%
|
Net Profit | -26 -26 |
20%
20%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Marpai, Inc. offers a SMART health plan services system that transforms health plan into a health empowerment tool. It provides health plan services system addresses the problems of healthcare. The firm uses deep learning, artificial intelligence, to empower people to live better, stay strong and spend less on healthcare. Its SMART health plan services enables companies to provide better healthcare to employees and significantly reduce administration, reinsurance and care costs. The company was founded in January 2021 and is headquartered in Tampa, FL.
Head office | United States |
CEO | Damien Lamendola |
Employees | 162 |
Founded | 2021 |
Website | www.marpaihealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.